Canlyniadau Chwilio - Stevenson, James M

Insights and barriers to clinical use of serotonin transporter pharmacogenetics in antidepressant therapy gan Stevenson, James M

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Risk Factors for Cardiovascular Events in Patients on Antidementia Medications gan He, Meiqi, Stevenson, James M., Zhang, Yuting, Hernandez, Inmaculada

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Projected Utility of Pharmacogenomic Testing Among Individuals Hospitalized With COVID‐19: A Retrospective Multicenter Study in the United States gan Stevenson, James M., Alexander, G. Caleb, Palamuttam, Natasha, Mehta, Hemalkumar B.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Pharmacogenetics: A Precision Medicine Approach to Combatting the Opioid Epidemic gan Smith, D. Max, Stevenson, James M., Ho, Teresa T., Formea, Christine M., Gammal, Roseann S., Cavallari, Larisa H.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Echinacea Purpurea Significantly Induces Cytochrome P450 3A (CYP3A) but does not alter Lopinavir-Ritonavir Exposure in Healthy Subjects gan Penzak, Scott R., Robertson, Sarah M., Hunt, Jennifer D., Chairez, Cheryl, Malati, Christine Y., Alfaro, Raul M., Stevenson, James M., Candidate, Pharm.D., Kovacs, Joseph A.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Evaluating the Extent of Reusability of CYP2C19 Genotype Data among Patients Genotyped for Antiplatelet Therapy Selection gan Beitelshees, Amber L., Stevenson, James M., El Rouby, Nihal, Dillon, Chrisly, Empey, Philip E., Fielstein, Elliot M., Johnson, Julie A., Limdi, Nita A., Ong, Henry H., Franchi, Francesco, Angiolillo, Dominick P., Peterson, Joshua F., Rosenman, Marc B., Skaar, Todd C., Tuteja, Sony, Cavallari, Larisa H.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Genome-wide association study accounting for anticholinergic burden to examine cognitive dysfunction in psychotic disorders gan Eum, Seenae, Hill, S. Kristian, Alliey-Rodriguez, Ney, Stevenson, James M., Rubin, Leah H., Lee, Adam M., Mills, Lauren J., Reilly, James L., Lencer, Rebekka, Keedy, Sarah K., Ivleva, Elena, Keefe, Richard S. E., Pearlson, Godfrey D., Clementz, Brett A., Tamminga, Carol A., Keshavan, Matcheri S., Gershon, Elliot S., Sweeney, John A., Bishop, Jeffrey R.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Impact of the CYP2C19*17 allele on outcomes in patients receiving genotype-guided antiplatelet therapy after percutaneous coronary intervention gan Lee, Craig R., Thomas, Cameron D., Beitelshees, Amber L., Tuteja, Sony, Empey, Philip E., Lee, James C., Limdi, Nita A., Duarte, Julio D., Skaar, Todd C., Chen, Yiqing, Cook, Kelsey J., Coons, James C., Dillon, Chrisly, Franchi, Francesco, Giri, Jay, Gong, Yan, Kreutz, Rolf P., McDonough, Caitrin W., Stevenson, James M., Weck, Karen E., Angiolillo, Dominick J., Johnson, Julie A., Stouffer, George A., Cavallari, Larisa H.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

CYP2C19 Genotype‐Guided Antiplatelet Therapy After Percutaneous Coronary Intervention in Diverse Clinical Settings gan Beitelshees, Amber L., Thomas, Cameron D., Empey, Philip E., Stouffer, George A., Angiolillo, Dominick J., Franchi, Francesco, Tuteja, Sony, Limdi, Nita A., Lee, James C., Duarte, Julio D., Kreutz, Rolf P., Skaar, Todd C., Coons, James C., Giri, Jay, McDonough, Caitrin W., Rowland, Rachel, Stevenson, James M., Thai, Thuy, Vesely, Mark R., Wellen, Jacob T., Johnson, Julie A., Winterstein, Almut G., Cavallari, Larisa H., Lee, Craig R.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Multi-site investigation of strategies for the implementation of CYP2C19 genotype-guided antiplatelet therapy gan Empey, Philip E., Stevenson, James M., Tuteja, Sony, Weitzel, Kristin W., Angiolillo, Dominick J., Beitelshees, Amber L., Coons, James C., Duarte, Julio D., Franchi, Francesco, Jeng, Linda J.B., Johnson, Julie A., Kreutz, Rolf P, Limdi, Nita A., Maloney, Kristin A., Obeng, Aniwaa Owusu, Peterson, Josh F., Petry, Natasha, Pratt, Victoria M., Rollini, Fabiana, Scott, Stuart A., Skaar, Todd C., Vesely, Mark R., Stouffer, George A., Wilke, Russell A., Cavallari, Larisa H., Lee, Craig R.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Multi-site Investigation of Outcomes with Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy after Percutaneous Coronary Intervention gan Cavallari, Larisa H., Lee, Craig R., Beitelshees, Amber L., Cooper-DeHoff, Rhonda M., Duarte, Julio D., Voora, Deepak, Kimmel, Stephen E., McDonough, Caitrin W., Gong, Yan, Dave, Chintan V., Pratt, Victoria M., Alestock, Tameka D., Anderson, R. David, Alsip, Jorge, Ardati, Amer K., Brott, Brigitta C., Brown, Lawrence, Chumnumwat, Supatat, Clare-Salzler, Michael J., Coons, James C., Denny, Joshua C., Dillon, Chrisly, Elsey, Amanda R., Hamadeh, Issam, Harada, Shuko, Hillegass, William B., Hines, Lindsay, Horenstein, Richard B., Howell, Lucius A., Jeng, Linda J.B., Kelemen, Mark D., Lee, Y.M., Magvanjav, Oyunbileg, Montasser, May, Nelson, David R., Nutescu, Edith A., Nwaba, Devon C., Pakyz, Ruth E., Palmer, Kathleen, Peterson, Josh F., Pollin, Toni I., Quinn, Alison H., Robinson, Shawn W., Schub, Jamie, Skaar, Todd C., Smith, Donald M., Sriramoju, Vindhya B., Starostik, Petr, Stys, Tomasz P., Stevenson, James M., Varunok, Nicholas, Vesely, Mark R., Wake, Dyson T., Weck, Karen E., Weitzel, Kristin W., Wilke, Russell A., Willig, James, Zhao, Richard Y., Kreutz, Rolf P., Stouffer, George A., Empey, Philip E., Limdi, Nita A., Shuldiner, Alan R., Winterstein, Almut G., Johnson, Julie A.

Cael y testun llawn Cael y testun llawn Cael y testun llawn